|
EP0809492A4
(en)
*
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US6054472A
(en)
*
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
|
CA2256492C
(en)
|
1996-05-20 |
2006-04-04 |
Teijin Limited |
Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
|
|
WO1997049399A1
(en)
*
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
WO1998005317A1
(en)
*
|
1996-08-06 |
1998-02-12 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
WO1998005329A1
(en)
|
1996-08-06 |
1998-02-12 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
WO1998006398A1
(en)
*
|
1996-08-15 |
1998-02-19 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
CA2268085A1
(en)
*
|
1996-10-22 |
1998-04-30 |
Go Wakabayashi |
Sepsis remedy comprising anti-il-8 antibody as active ingredient
|
|
DE19651040C2
(de)
*
|
1996-12-09 |
1999-01-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Amino-5-alkyl-phenolen
|
|
KR20000070368A
(ko)
*
|
1997-01-23 |
2000-11-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
인터루킨-8 수용체 길항제
|
|
US6436927B1
(en)
|
1997-02-12 |
2002-08-20 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
ES2224365T3
(es)
*
|
1997-02-12 |
2005-03-01 |
Smithkline Beecham Corporation |
Antagonistas de receptores de il-8.
|
|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
|
EP1014962A4
(en)
*
|
1997-06-26 |
2007-06-27 |
Lilly Co Eli |
ANTITHROMBOTIC AGENTS
|
|
AU8673198A
(en)
*
|
1997-07-29 |
1999-02-22 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
US7067117B1
(en)
|
1997-09-11 |
2006-06-27 |
Cambridge University Technical Services, Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
US6989435B2
(en)
|
1997-09-11 |
2006-01-24 |
Cambridge University Technical Services Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
NZ505843A
(en)
*
|
1997-12-22 |
2003-06-30 |
Bayer Ag |
Diphenyl ureas compounds for treating cancer and raf kinase related diseases
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
JP4437270B2
(ja)
*
|
1997-12-22 |
2010-03-24 |
バイエル コーポレイション |
置換複素環式尿素を用いたｒａｆキナーゼの阻害
|
|
US20080300281A1
(en)
*
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
|
AU2003204708B2
(en)
*
|
1997-12-22 |
2006-05-25 |
Bayer Healthcare Llc |
Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
|
|
WO1999065310A1
(en)
*
|
1998-06-17 |
1999-12-23 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
BR9815951A
(pt)
*
|
1998-07-23 |
2001-03-06 |
Smithkline Beecham Corp |
Antagonistas do receptor de il-8
|
|
CA2341718A1
(en)
*
|
1998-08-28 |
2000-03-09 |
Neil H. Baine |
An improved synthesis of 3-hydroxy-4-amino-benzonitrile
|
|
PL198852B1
(pl)
*
|
1998-10-22 |
2008-07-31 |
Neurosearch As |
Podstawione pochodne fenylu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
|
|
US6262090B1
(en)
|
1998-12-09 |
2001-07-17 |
American Home Products Corporation |
Aminopyridine-containing thiourea inhibitors of herpes viruses
|
|
US6207715B1
(en)
|
1998-12-09 |
2001-03-27 |
American Home Products Corporation |
Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a substituted phenylene-diamine group
|
|
US6255349B1
(en)
|
1998-12-09 |
2001-07-03 |
American Home Products Corporation |
Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
|
|
US6166028A
(en)
|
1998-12-09 |
2000-12-26 |
American Home Products Corporation |
Diaminopuridine-containing thiourea inhibitors of herpes viruses
|
|
US6197803B1
(en)
|
1998-12-09 |
2001-03-06 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
|
|
JP2002531545A
(ja)
*
|
1998-12-09 |
2002-09-24 |
ワイス |
ヘルペスウイルスのチオ尿素インヒビター
|
|
US6335350B1
(en)
|
1998-12-09 |
2002-01-01 |
American Home Products Corporation |
Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
|
|
JP2002531555A
(ja)
*
|
1998-12-09 |
2002-09-24 |
ワイス |
フェニレンジアミン基を含む、アルファ−メチルベンジル−含有の、ヘルペスウイルスのチオ尿素インヒビター
|
|
US6201013B1
(en)
|
1998-12-09 |
2001-03-13 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
|
|
US20080269265A1
(en)
*
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
US7351834B1
(en)
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1140840B1
(en)
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1158985B1
(en)
|
1999-01-13 |
2011-12-28 |
Bayer HealthCare LLC |
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
MXPA01008440A
(es)
|
1999-02-22 |
2002-04-24 |
Boehringer Ingelheim Pharma |
Derivados heterociclicos policiclos como agentes anti-inflamatorios..
|
|
DE60023853T2
(de)
*
|
1999-03-12 |
2006-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
|
|
HUP0202248A3
(en)
|
1999-03-12 |
2006-06-28 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
|
SK13132001A3
(sk)
*
|
1999-03-17 |
2002-02-05 |
Astrazeneca Ab |
Amidové deriváty, spôsob ich prípravy, farmaceutická kompozícia, ktorá ich obsahuje, a ich použitie
|
|
AR029361A1
(es)
*
|
1999-05-28 |
2003-06-25 |
Smithkline Beecham Corp |
Compuestos de guanidina ciclicas antagonistas de los receptores de la il- 8, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento
|
|
CO5190710A1
(es)
*
|
1999-06-15 |
2002-08-29 |
Smithkline Beecham Corp |
Antagonistas de un receptor de il-8 un receptor de il-8
|
|
CO5200760A1
(es)
*
|
1999-06-16 |
2002-09-27 |
Smithkline Beecham Corp |
Antagonistas del receptor de la il-8 ceptor il-8
|
|
ES2292461T3
(es)
*
|
1999-07-07 |
2008-03-16 |
Astrazeneca Uk Limited |
Derivados de quinazolina.
|
|
MXPA02000314A
(es)
|
1999-07-09 |
2004-06-22 |
Boehringer Ingelheim Pharma |
Proceso novedoso para la sintesis de compuestos de urea substituidos con heteroarilo.
|
|
WO2001007411A1
(en)
|
1999-07-26 |
2001-02-01 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
|
CO5271663A1
(es)
*
|
1999-11-09 |
2003-04-30 |
Smithkline Beecham Corp |
Antagonistas del receptor il-8
|
|
CA2389360C
(en)
|
1999-11-16 |
2008-06-03 |
Steffen Breitfelder |
Urea derivatives as anti-inflammatory agents
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
EP1274413A4
(en)
*
|
2000-03-01 |
2005-08-10 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
JP2004504270A
(ja)
*
|
2000-03-10 |
2004-02-12 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８受容体アンタゴニスト
|
|
MY133845A
(en)
*
|
2000-03-10 |
2007-11-30 |
Smithkline Beecham Corp |
Il-8 receptor antagonists
|
|
WO2001068569A2
(en)
*
|
2000-03-14 |
2001-09-20 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
AR031098A1
(es)
*
|
2000-03-16 |
2003-09-10 |
Smithkline Beecham Corp |
Compuestos de hidroxifenil urea sustituidos con sulfonamidas, composiciones farmaceuticas que los comprenden, y uso de los mismos en la fabricacion de medicamentos para tratar una enfermedad mediada por una quimioquina
|
|
UY26627A1
(es)
*
|
2000-03-24 |
2001-09-28 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
CA2405690A1
(en)
*
|
2000-04-14 |
2002-10-09 |
Kureha Chemical Industry Company, Limited |
Nitrogen-containing compounds and antiviral drugs containing the same
|
|
WO2001092202A1
(en)
*
|
2000-05-30 |
2001-12-06 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
CZ2003132A3
(cs)
*
|
2000-07-18 |
2003-09-17 |
Smithkline Beecham Corporation |
Farmaceutický prostředek pro léčení příznaků běžného nachlazení
|
|
AU2001290852A1
(en)
*
|
2000-09-15 |
2002-03-26 |
Iconix Pharmaceuticals, Inc. |
Inhibitors of rho c
|
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
DE60230722D1
(de)
*
|
2001-01-16 |
2009-02-26 |
Smithkline Beecham Corp |
Il-8-rezeptor-antagonisten
|
|
WO2002057230A1
(en)
*
|
2001-01-16 |
2002-07-25 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
DE10109204A1
(de)
*
|
2001-02-26 |
2002-09-19 |
4Sc Ag |
Verbindungen zur Behandlung von Protozoen-Erkrankungen
|
|
WO2002070467A1
(en)
|
2001-02-26 |
2002-09-12 |
4Sc Ag |
Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
|
|
ITMI20010395A1
(it)
|
2001-02-27 |
2002-08-27 |
Dompe Spa |
Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
|
|
CA2439255C
(en)
|
2001-02-28 |
2011-01-04 |
Temple University Of The Commonwealth System Of Higher Education |
N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
|
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
CN1630517A
(zh)
*
|
2001-05-24 |
2005-06-22 |
吴羽化学工业株式会社 |
包含含氮化合物的具有cxcr4拮抗作用的药物
|
|
US20040038854A1
(en)
*
|
2001-07-16 |
2004-02-26 |
Dillon Susan B. |
Use of il-8 receptor antagonists in the treatment of virus infections
|
|
US6791892B2
(en)
*
|
2001-07-18 |
2004-09-14 |
Samsung Electronics Co., Ltd. |
Method of generating an initializing signal during power-up of semiconductor memory device
|
|
ES2400070T3
(es)
*
|
2001-12-03 |
2013-04-05 |
Bayer Healthcare Llc |
Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
|
|
US20080108672A1
(en)
*
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
|
CA2475818C
(en)
*
|
2002-02-11 |
2011-07-19 |
Bayer Pharmaceuticals Corporation |
Aryl ureas as kinase inhibitors
|
|
ES2425739T3
(es)
*
|
2002-02-11 |
2013-10-17 |
Bayer Healthcare Llc |
Sorafenib-tosilato para el tratamiento de enfermedades caracterizadas por angiogénesis anormal
|
|
US20040023961A1
(en)
*
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
AU2003209119A1
(en)
*
|
2002-02-11 |
2003-09-04 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
|
EP1480973B1
(en)
|
2002-02-25 |
2008-02-13 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
|
IL163608A0
(en)
*
|
2002-02-28 |
2005-12-18 |
Univ Temple |
Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
|
|
KR20030080509A
(ko)
*
|
2002-04-09 |
2003-10-17 |
주식회사 엘지생명과학 |
우레아, 티오우레아 및 설파마이드 유도체를 함유하는항균제 조성물
|
|
US20030236287A1
(en)
*
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
ATE372770T1
(de)
*
|
2002-08-01 |
2007-09-15 |
Neurosearch As |
Verbindungen nützlich in der behandlung von erkrankungen die auf anti-angiogenertherapie antworten
|
|
JP3714948B2
(ja)
*
|
2002-09-11 |
2005-11-09 |
呉羽化学工業株式会社 |
アミン化合物及びその用途
|
|
EP1402887A1
(en)
*
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
|
TW200418812A
(en)
|
2002-10-29 |
2004-10-01 |
Smithkline Beecham Corp |
IL-8 receptor antagonists
|
|
DE10251830A1
(de)
*
|
2002-11-07 |
2004-05-19 |
Wella Ag |
2-Amino-5-ethylphenol enthaltendes Mittel zum Färben von Keratinfasern
|
|
DE60327652D1
(de)
*
|
2002-11-21 |
2009-06-25 |
Neurosearch As |
Diarylureidoderivate und deren medizinische verwendung
|
|
WO2004058683A2
(en)
*
|
2002-12-20 |
2004-07-15 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
WO2004058722A1
(en)
*
|
2002-12-24 |
2004-07-15 |
Arena Pharmaceuticals, Inc. |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
US7220768B2
(en)
*
|
2003-02-11 |
2007-05-22 |
Wyeth Holdings Corp. |
Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
|
|
AU2004212633B2
(en)
*
|
2003-02-21 |
2010-12-09 |
ResMed Pty Ltd |
Nasal assembly
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
EP1457485A1
(en)
*
|
2003-03-14 |
2004-09-15 |
Dompé S.P.A. |
Sulfonic acids, their derivatives and pharmaceutical compositions containing them
|
|
WO2004089296A2
(en)
*
|
2003-04-03 |
2004-10-21 |
The Regents Of The University Of California |
Improved inhibitors for the soluble epoxide hydrolase
|
|
DE602004011340T2
(de)
|
2003-05-20 |
2008-11-06 |
Bayer Healthcare Llc |
Diaryl-harnstoffe mit kinasehemmender wirkung
|
|
RS20060035A
(sr)
*
|
2003-07-22 |
2008-08-07 |
Arena Pharmaceuticals Inc., |
Derivati diaril i arilheteroaril uree kao modulatori receptora 5-ht2a serotonina korisni u profilaksi i lečenju poremećaja u vezi sa njima
|
|
NZ544920A
(en)
|
2003-07-23 |
2009-11-27 |
Bayer Healthcare Llc |
4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
|
|
US7851492B2
(en)
|
2003-09-04 |
2010-12-14 |
Neurosearch A/S |
ERG channel openers for the treatment of cardiac arrhythmias
|
|
WO2005023238A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Poseidon Pharmaceuticals A/S |
Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
CA2558600C
(en)
*
|
2004-03-10 |
2013-07-09 |
Kureha Corporation |
A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
|
|
CA2559665A1
(en)
|
2004-03-16 |
2005-09-29 |
The Regents Of The University Of California |
Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids
|
|
WO2005103011A1
(en)
*
|
2004-03-23 |
2005-11-03 |
Arena Pharmaceuticals, Inc. |
Processes for preparing substituted n-aryl-n’-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof
|
|
AU2005225559A1
(en)
*
|
2004-03-29 |
2005-10-06 |
Neurosearch A/S |
Novel urea derivatives and their medical use
|
|
JP2007535565A
(ja)
|
2004-04-30 |
2007-12-06 |
バイエル ファーマシューティカルス コーポレーション |
癌の治療に有用な置換ピラゾリル尿素誘導体
|
|
ES2340179T3
(es)
*
|
2004-05-12 |
2010-05-31 |
Bristol-Myers Squibb Company |
Antagonistas de urea del receptor p2y1 utiles en el tratamiento de afecciones tromboticas.
|
|
US7550499B2
(en)
|
2004-05-12 |
2009-06-23 |
Bristol-Myers Squibb Company |
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
CN1984899B
(zh)
*
|
2004-05-12 |
2011-07-27 |
先灵公司 |
Cxcr1和cxcr2趋化因子拮抗剂
|
|
FR2872159B1
(fr)
*
|
2004-06-28 |
2007-10-05 |
Merck Sante Soc Par Actions Si |
Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
|
|
HRP20080608T3
(hr)
|
2004-08-12 |
2008-12-31 |
Pfizer Inc. |
Triazolopiridinilsulfanilni derivati kao inhibitori p38 map kinaze
|
|
AU2005277582A1
(en)
*
|
2004-08-16 |
2006-03-02 |
The Procter & Gamble Company |
2-(amino or substituted amino)-5, 6-substituted phenol compounds, dyeing compositions containing them, and use thereof
|
|
EP1634573A1
(en)
*
|
2004-08-16 |
2006-03-15 |
The Procter and Gamble Company |
2-(Amino or substituted Amino)-5,6-substituted Phenol compounds, dyeing compositions containing them, and use thereof
|
|
NZ554555A
(en)
*
|
2004-10-20 |
2011-09-30 |
Univ California |
Cyclohexyl-urea derivatives as improved inhibitors for the soluble epoxide hydrolase
|
|
US20070249625A1
(en)
*
|
2004-10-20 |
2007-10-25 |
Jakob Busch-Petersen |
Il-8 Receptor Antagonists
|
|
CA2580690A1
(en)
|
2004-10-21 |
2006-05-04 |
Transtech Pharma, Inc. |
Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
|
|
PE20061130A1
(es)
*
|
2004-11-19 |
2007-01-05 |
Arena Pharm Inc |
Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a
|
|
US20080015223A1
(en)
*
|
2004-12-03 |
2008-01-17 |
Arena Pharmaceuticals, Inc. |
Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
|
|
AU2006206611A1
(en)
|
2005-01-19 |
2006-07-27 |
Bristol-Myers Squibb Company |
2-phenoxy-N- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as P2Y1 receptor inhibitors for the treatment of thromboembolic disorders
|
|
EP1843762A1
(en)
*
|
2005-01-19 |
2007-10-17 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
|
|
WO2006101439A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Astrazeneca Ab |
Screen
|
|
US7714002B2
(en)
|
2005-06-27 |
2010-05-11 |
Bristol-Myers Squibb Company |
Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
MX2007016501A
(es)
|
2005-06-27 |
2008-03-06 |
Squibb Bristol Myers Co |
Antagonistas heterociclicos n-enlazados del receptor de p2y1, utiles en el tratamiento de condiciones tromboticas.
|
|
EP1899299B1
(en)
|
2005-06-27 |
2010-10-20 |
Bristol-Myers Squibb Company |
C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
|
|
ES2360818T3
(es)
|
2005-06-27 |
2011-06-09 |
Bristol-Myers Squibb Company |
Miméticos de urea lineal antagonistas del receptor p2y, útiles en el tratamiento de afecciones trombóticas.
|
|
GB0526255D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
TW200806641A
(en)
*
|
2006-01-25 |
2008-02-01 |
Synta Pharmaceuticals Corp |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
MX2008013599A
(es)
*
|
2006-04-21 |
2008-10-31 |
Smithkline Beechman Corp |
Antagonistas del receptor il-8.
|
|
EP2009992B1
(en)
*
|
2006-04-21 |
2012-06-27 |
GlaxoSmithKline LLC |
Il-8 receptor antagonists
|
|
WO2007127930A2
(en)
*
|
2006-04-28 |
2007-11-08 |
Kansas State University Research Foundation |
Compounds affecting gap junction activity
|
|
CN101479261A
(zh)
|
2006-05-18 |
2009-07-08 |
艾尼纳制药公司 |
3-吡唑基-苯甲酰胺-4-醚、其仲胺及其衍生物作为5-ht2a血清素受体的调节剂用于治疗与其相关的病症
|
|
ES2536762T3
(es)
|
2006-05-18 |
2015-05-28 |
Arena Pharmaceuticals, Inc. |
Aminas primarias y sus derivados como moduladores del receptor de la serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con este
|
|
MX349156B
(es)
|
2006-05-18 |
2017-07-14 |
Arena Pharm Inc |
Formas cristalinas y procesos para la preparacion de fenil-pirazoles utiles como moduladores del receptor de serotonina 5-ht2a.
|
|
TW200817006A
(en)
*
|
2006-06-23 |
2008-04-16 |
Smithkline Beecham Corp |
IL-8 receptor antagonist
|
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
US7960569B2
(en)
|
2006-10-17 |
2011-06-14 |
Bristol-Myers Squibb Company |
Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
WO2008047067A1
(en)
*
|
2006-10-20 |
2008-04-24 |
University Court Of The University Of Edinburgh |
Treatment of inflammatory disease
|
|
EP2190844B3
(en)
|
2007-08-15 |
2013-07-17 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
AU2008309003A1
(en)
*
|
2007-09-28 |
2009-04-09 |
Glaxosmithkline Llc |
Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
|
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
RS57110B1
(sr)
|
2008-10-28 |
2018-06-29 |
Arena Pharm Inc |
Sastavi modulatora 5-ht2a serotoninskog receptora korisni za tretiranje poremećaja povezanih sa njim
|
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
|
WO2010092440A1
(en)
*
|
2009-02-16 |
2010-08-19 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Cxcr2 receptor antagonists for the treatment or the prevention of insulin resistance
|
|
WO2011022028A2
(en)
*
|
2009-05-18 |
2011-02-24 |
Tufts University |
Small molecule antagonists of phosphatidylinositol-3, 4, 5-triphosphate (pip3) and uses thereof
|
|
WO2011073248A1
(en)
*
|
2009-12-17 |
2011-06-23 |
Galderma Research & Development |
Use of compounds in the treatment or prevention of skin disorders
|
|
US8980891B2
(en)
|
2009-12-18 |
2015-03-17 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
BRPI1004176A2
(pt)
*
|
2010-10-25 |
2015-08-11 |
Univ Rio De Janeiro |
Compostos aril e/ou hetero aril uréias funcionalizados; processo de síntese desses composto; composição farmacêutica contendo tais compostos e usos
|
|
US8648118B2
(en)
|
2010-12-17 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
Bicyclic ring system substituted amide functionalised phenols as medicaments
|
|
EP2712655B1
(en)
|
2011-04-28 |
2019-12-18 |
The Broad Institute, Inc. |
Inhibitors of histone deacetylase
|
|
WO2014018979A1
(en)
|
2012-07-27 |
2014-01-30 |
The Broad Institute, Inc. |
Inhibitors of histone deacetylase
|
|
US9518011B2
(en)
|
2012-11-21 |
2016-12-13 |
Nippon Soda Co., Ltd. |
Recording material produced using non-phenol compound
|
|
WO2014100438A1
(en)
|
2012-12-20 |
2014-06-26 |
The Broad Institute, Inc. |
Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
|
|
CN104995033B
(zh)
*
|
2013-02-13 |
2017-10-13 |
王子控股株式会社 |
热敏记录体
|
|
WO2014189044A1
(ja)
*
|
2013-05-22 |
2014-11-27 |
王子ホールディングス株式会社 |
感熱記録体
|
|
AU2016276966A1
(en)
|
2015-06-12 |
2018-01-18 |
Axovant Sciences Gmbh |
Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of REM sleep behavior disorder
|
|
EP3117835A1
(en)
*
|
2015-07-14 |
2017-01-18 |
Dompé farmaceutici s.p.a. |
Il-8 inhibitors for use in the treatment of certain urological disorders
|
|
EP3322415A4
(en)
|
2015-07-15 |
2019-03-13 |
Axovant Sciences GmbH |
DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR FOR PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS RELATED TO A NEUROGENERATIVE DISEASE
|
|
US10093617B1
(en)
|
2015-10-30 |
2018-10-09 |
Sumitomo Chemical Company, Limited |
Method for producing 2-amino-4-substituted phenol
|
|
JP7092356B2
(ja)
*
|
2016-06-22 |
2022-06-28 |
フーダン ユニヴァーシティ |
ビアリール尿素誘導体またはそれらの塩、およびそれらの調製方法および使用
|
|
CN107522641B
(zh)
*
|
2016-06-22 |
2020-05-05 |
复旦大学 |
联芳基脲类衍生物或其盐及其制备方法和用途
|
|
CN117503933A
(zh)
*
|
2016-10-03 |
2024-02-06 |
儿童医疗中心公司 |
糖尿病肾病的预防和治疗
|
|
US12128018B2
(en)
|
2018-01-12 |
2024-10-29 |
KDAc Therapeutics, Inc. |
Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer
|
|
CN110698373A
(zh)
*
|
2019-11-07 |
2020-01-17 |
温州大学 |
N-（2-（甲硫基）苯基）乙酰胺类化合物的制备方法及其净化提纯方法
|
|
CN112321452B
(zh)
*
|
2020-09-11 |
2022-11-29 |
北京红惠新医药科技有限公司 |
厚朴酚衍生物、和厚朴酚衍生物及其盐酸盐、制备方法及应用
|
|
WO2025121190A1
(ja)
*
|
2023-12-08 |
2025-06-12 |
日産化学株式会社 |
重合体、樹脂組成物、液晶配向剤、樹脂被膜及び液晶配向膜
|